BeOne Medicines (STU:IJ0) Marketable Securities : €0 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is BeOne Medicines Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. BeOne Medicines's Marketable Securities for the quarter that ended in Mar. 2025 was €0 Mil.

BeOne Medicines's annual Marketable Securities declined from Dec. 2022 (€628 Mil) to Dec. 2023 (€0 Mil) but then stayed the same from Dec. 2023 (€0 Mil) to Dec. 2024 (€0 Mil).

BeOne Medicines Marketable Securities Historical Data

The historical data trend for BeOne Medicines's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BeOne Medicines Marketable Securities Chart

BeOne Medicines Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Marketable Securities

Get a 7-Day Free Trial

2,686.89

1,984.14

628.00

BeOne Medicines Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Marketable Securities	Get a 7-Day Free Trial															-	-	-	-	-

BeOne Medicines Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

BeOne Medicines (STU:IJ0) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

BeOne Medicines Marketable Securities Related Terms

Thank you for viewing the detailed overview of BeOne Medicines's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

BeOne Medicines Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeOne Medicines Ltd (STU:IJ0) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

BEIGF:USA ONC:USA 06160:Hong Kong 688235:China B1ME34:Brazil

Address

c/o BeOne Medicines I GmbH, Aeschengraben 27, 21st Floor, Basel, CHE, 4051

Website

https://www.beonemedicines.com

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.

BeOne Medicines Headlines

No Headlines